Adoptively transferred tumor-draining lymph node–derived T cells recognize the neoantigen peptide–HLA class I complex via their native TCRs and directly kill target cells through CTL effector mechanisms (perforin/granzyme release and Fas–FasL apoptosis), aided by cytotoxic cytokines.